PlanVest Financial’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$238 Hold
28
– – ﹤0.01% 581
2026
Q2
$321 Hold
28
– – ﹤0.01% 572
2026
Q1
$132 Buy
+28
New +$171 ﹤0.01% 552

Other funds holding ATRA

PlanVest Financial's ATRA Position: Q3 2026 in Review

PlanVest Financial held its Atara Biotherapeutics (ATRA) position steady in Q3 2026 at 28 shares worth $238. The position accounts for ﹤0.01% of the portfolio, ranked #581.

PlanVest Financial first reported a position in ATRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $321 in Q2 2026. 36 funds tracked by Wall St. Rank hold ATRA as of Q3 2026.

  • PlanVest Financial held 28 shares of Atara Biotherapeutics worth $238 as of Q3 2026.
  • PlanVest Financial left its Atara Biotherapeutics share count unchanged in Q3 2026.
  • Atara Biotherapeutics made up ﹤0.01% of PlanVest Financial's portfolio in Q3 2026, its #581 holding.
  • PlanVest Financial first reported a position in Atara Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
  • PlanVest Financial's Atara Biotherapeutics position peaked at $321 in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2026.

Based on PlanVest Financial's 13F filing for Q3 2026, filed 9 Nov 2026.